Up to 90% of patients who undergo total hip or knee replacement receive blood products, despite safety concerns and overuse of blood components.

A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.

In his book The Master Algorithm, Pedro Domingos offers a masterfully simple definition: “An algorithm is,” Domingos writes, “a sequence of instructions telling a computer what to do.” ...